Ventura County’s technology corridor has kicked off 2013 with $173 million in deal activity. Thousand Oaks-based Nexsan Corp., a maker of hard-disk storage arrays for mid-sized businesses, said Jan. 2 that it had been acquired by Minnesota-based Imation Corp. for $120 million. Oxnard-based wireless products company CalAmp Corp. said Dec. 20 that it is buying Read More →
Thousand Oaks-based Amgen has entered a deal to pay up to $180.5 million for nanomedicine tumor treatments being developed by a Massachusetts company. Cambridge-based Bind Biosciences said it has entered a development agreement with Amgen for its kinase inhibitor nanomedicines for treating a range of solid tumors. The medicines are highly targeted and can be Read More →
Thousand Oaks-based Nexsan Corp., a maker of hard-disk storage arrays for mid-sized businesses, has been purchased by Imation Corp. for $120 million. Imation will pay $105 million in cash and 3.3 million common shares, worth about $15 million, for the Thousand Oaks firm. Nexsan is privately held but kicked off an unsuccessful bid to go Read More →
Oxnard-based wireless products company CalAmp Corp. said Dec. 20 that it is buying the U.S. operations of Wireless Matrix Corp. for $53 million in cash. CalAmp said it expects the deal, which will likely close in the first quarter of 2013, to be accretive to its non-GAAP earnings starting in 2014. Wireless Matrix is a Read More →
Santa Barbara-based manufacturing software firm QAD said Dec. 31 that it purchased Michigan-based Cebos for $5 million in cash. QAD sells planning and management software used by large manufacturing firms around the world. Cebos provides management and regulatory compliance software. QAD will pay $3.5 million upon closing the deal and then $1.5 million subject to Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Biotech giant Amgen is buying Icelandic genetics research firm DeCode Genetics for $415 million, the Thousand Oaks company said Dec. 10. The all-cash deal is expected to close before the end of the year and will give Amgen, the largest biotechnology firm in the world, opportunities to develop new medicines that target defective DNA. “DeCode Read More →